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In isolated rat hepatocytes phenylephrine promotes a rapid increase in the amount of pyruvate 
dehydrogenase present in its active form (PD&). This action is mediated by cur-adrenergic re eptors and 
is not observed in Ca’+-depleted hepatocytes. It is mimicked by the Ca” ionophore A23187. No changes 
in metabolites known to affect PDH activity are measured 3 min after addition of phenylephrine. 
Glucagon also increases PDH,, its action is additive to that of phenylephrine. The action of phenylephrine 
on PDH, could be explained by an increase in mitochondrial free Ca*+. 
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1. INTRODUCTION 
The administration of vasopressin to the perfus- 
ed rat liver leads to a rapid increase in the amount 
of pyruvate dehy~ogen~e (PDH) present in its 
active, non-phosphorylated, form [I 1. The same 
effect has been observed in isolated hepatocytes 
[2,3] in which it was found that angiotensin and 
phenylephrine activate pyruvate dehydrogenase in 
a similar manner. The amount of mammalian 
pyruvate dehy~ogen~e complex present in its ac- 
tive, non-phosphorylated form is determined by 
the relative activities of its interconverting 
phosphatase and kinase, each of which is control- 
led by various effecters [4,5]. The phosphatase is 
activated by Mgzg2+ (&.s = 1 mM, where kr0.5 is the 
concentration required for half-maximal effect) 
and by Ca2+ (K0.s = 1 pM). The Mg-ATP- 
dependent kinase is inhibited by pyruvate, ADP 
and perhaps Ca2+ and activated by increases in the 
ratios of NADH/NAD and acetyl CoA/CoA (see 
[S] for review). 
kinase by increasing the concentration of Ca2+ in 
the cytosol of liver cells [6-91. However, the origin 
of this calcium is still under debate. 
Among the mechanisms which could explain the 
activation of PDH by vasopressin, an increase in 
mitochondrial Ca” would be the most likely, since 
measurements of whole tissue concentration of 
metabolites known to affect PDH kinase or 
phosphatase could not explain the activation of the 
enzyme [l]. This postulated increase in mitochon- 
drial Ca2+ is however in contradiction with 
measurements of Ca2+ in mitochondria prepared 
from hepatocytes [lO,l l] or perfused liver [12] 
after addition of vasopressin or phenylephrine. 
This study was undertaken to explore the 
possibility that the fu-adrenergic activation of 
pyruvate dehydrogenase is accomplished by an in- 
crease in mitochondrial Ca’+, by trying to answer 
the following questions: 
Vasopressin, angiotensin and cur-adrenergic 
agents are thought to activate phosphorylase 
(i) Do cY-adrenergic agonists modify PDH activi- 
ty through ar (mediating Ca2+ changes) or a2 
receptors? 
(ii) Is this action Ca2’-dependent? 
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(iii) Can the increase in PDH activity be due to 
changes in concentrations of metabolites 
known to modify the activity of PDH kinase 
or phosphatase? 
(iv) How do a-adrenergic agents interact with the 
action of insulin and glucagon on PDH 
activity? 
2. MATERIALS AND METHODS 
Hepatocytes from fed 250 g male SIVZ (a 
Wistar-derived strain) rats were prepared by col- 
lagenase digestion [ 13,141. They were preincubated 
and incubated in a Krebs-Ringer bicarbonate buf- 
fer containing 3% dialyzed bovine albumin (frac- 
tion V Sigma) and 10 mM glucose. For calcium- 
free experiments hepatocytes were preincubated 
and incubated in Krebs-Ringer bicarbonate buffer 
containing no calcium and 0.5 mM EGTA. Cell 
viability estimated by trypan blue exclusion was 
> 92%. 
After the incubation, aliquots (1 ml) of cells 
were centrifuged (10 s), the supernatant removed 
and the pellet frozen in liquid nitrogen for subse- 
quent determination of pyruvate dehydrogenase 
activity or ATP, ADP, pyruvate, acetoacetate, ,& 
hydroxybutyrate and coenzyme A. Another ali- 
quot of cell plus medium was immediately frozen 
and later thawed in 5 vol. of 100 mM NaF/20 mM 
EDTA/O.S% glycogen in a 100 mM glycylglycine 
buffer (pH 7.4). Phosphorylase a activity was 
determined as in [15,16]. 
For the determination of pyruvate 
dehydrogenase activity, the frozen cell pellets 
(100 mg wet wt/ml) were extracted at 0°C by 
disruption (at least 10 passages) in a 1 ml syringe 
fitted with a 0.6 mm diam. needle in 100 mM 
KHzP04 (PH 7.3), 2 mM EDTA/l mM 
dithiothreitol/O. 1% Triton X-100 which contained 
50 gl/ml of rat serum to prevent proteolysis [ 171, 
and then frozen and thawed 3-times. The suspen- 
sion was then thawed and spun for 30 s in a cen- 
trifuge (Eppendorf 3200), and the supernatant was 
assayed for pyruvate dehydrogenase activity [ 181. 
This activity is referred to as ‘initial activity’ 
(PDH.). No activity was sedimented with the pellet 
fraction. One unit of pyruvate dehydrogenase ac- 
tivity is that amount which catalyses the transfor- 
mation of pyruvate at the rate of 1 ,umol/min at 
30°C. 
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For measurements of oxygen consumption, 
hepatocytes (25 mg/ml) were pre-equilibrated at 
37°C with 95% 02/5% CO2 to reach 60-70% ox- 
ygen saturation and transferred to the oxygen 
chamber (Rank Brother Co., Cambridge). Basal 
oxygen consumption was recorded for 5-7 min 
before the addition of hormone. The absolute 
values of oxygen consumption under control con- 
ditions varied from one cell preparation to 
another: 1.66 f 0.11 pmol 02. min-’ . g-’ (n = 4). 
Since phenylephrine increased oxygen consump- 
tion by only 20-30% the agonist effect was ex- 
pressed in percent change vs control. For the deter- 
mination of ATP, ADP, pyruvate, acetoacetate, ,& 
( - )hydroxybutyrate and coenzyme A, the cell 
pellet was homogenized in 1 M HC104, then cen- 
trifuged, the supernatant was neutralized and the 
metabolites measured as in [19]. 
Except where stated, results are given as mean + 
SEM for a given number of different cell prepara- 
tions. Each value used to calculate the mean was 
derived from triplicate incubations. The data are 
expressed/g wet wt of hepatocytes. 
Phenylephrine bitartrate was from Sigma. 
Regular Insulin U-40 was obtained from E.L. Lilly 
(Indianapolis IN), glucagon from Novo, Den- 
mark. Prazozin was a gift from Pfizer AG, 
Belgium. Yohimbine was from C. Roth 
(Karlsruhe), all the enzymes, coenzymes were from 
Boehringer (Mannheim). 
3. RESULTS 
3.1. Activation of PDH by phenylephrine and by 
the Cd’ ionophore A23187 
Phenylephrine promotes a rapid increase in the 
amount of active, non-phosphorylated pyruvate 
dehydrogenase (PDH.) (fig.1). The action is max- 
imal after 1 min. Shorter time points have not been 
measured (the error on time introduced by the 10 s 
centrifugation would be too large). The effect on 
PDH, lasts at least 20 min. When the hepatocytes 
are preincubated and incubated in a Ca’+-free 
medium containing 0.5 mM EGTA, they do not 
respond anymore to phenylephrine by an increase 
in PDH, (table 1). A slight, but significant increase 
in phosphorylase activity is still observed (table 1). 
Addition of the Ca2+ ionophore A23187 to 
hepatocytes incubated in a buffer containing Ca2+ 
is followed by a rapid and long-lasting increase in 
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Fig.1. Effect of phenylephrine and of the Ca2+ 
ionophore A23187 on ‘initial’ pyruvate dehydrogenase 
activity in isolated hepatocytes from fed rats. ** p < 
0.005 using paired Student’s t-test. 
PDH,. This increase is not observed when Ca2+ is 
omitted from the medium (not shown). The dose- 
dependence for phenylephrine of PDH activation 
is quite similar to that of phosphorylase activation 
(fig.2). 
3.2. Suppression of the effect of phenylephrine 
on PDH activity and oxygen consumption by 
cul-adrenergic blockers 
Table 1 shows that the al-antagonist prazozin at 
a concentration inhibiting phosphorylase activa- 
tion by adrenergic agents also suppresses the 
phenylephrine ffects in the activation of PDH and 
the stimulation of oxygen consumption, whereas 
the cr2 antagonist, yohimbine, does not modify 
these actions. 
3.3. Absence of action of phenylephrine on 
A TP/ADP, pyruvate, coenqvme A and 
mitochondrial NADH/NAD ratio 
Phenylephrine increases fructose 2,6-bisphos- 
phate in hepatocytes [ZO] and thereby may increase 
glycolysis and pyruvate concentration. Since PDH 
activity can be modified by several metabolites 
(among which pyruvate), or coenzymes, their level 
was measured in isolated hepatocytes 3 min after 
the addition of phenylephrine, a time at which the 
effect of the agonist on PDH is maximal. Table 2 
shows that neither ATP, ADP, pyruvate, coen- 
Table 1 
Effect of phenylephrine on phosphorylase, on ‘initial’ pyruvate dehydrogenase activity and 
on oxygen consumption in normal and Ca2+ -depleted hepatocytes: addition of prazozin and 
yohimbine 
Addition Phosphorylase 
(units/g) 
PDH 
(munits/g) 
02 consumption 
(To of control) 
Normal hepatocytes 
Control 
Prazozin 10e6 M 
Yohimbine 5 x 10e6 M 
Phenylephrine 5 x 10e6 M 
Phenylephrine + prazozin 
Phenylephrine + yohimbine 
Ca2+-depleted hepatocytes 
Control 
Phenylephrine 5 x 10m6 M 
6.2 f 0.9 
7.4 f 1.5 
7.3 f 1.8 
17.8 + 0.9” 
7.6 f l.gb 
17.0 f 1.4a 
2.2 + 0.2 
5.9 f o.2a 
0.15 f 0.03 
0.16 f 0.03 
0.15 f 0.02 
0.28 f 0.03a 127 + la 
0.18 f 0.02b 96 f 2b 
0.26 f 0.03* 124 f 6 
0.09 f 0.01 
0.07 f 0.01 106 f 3 
a Significantly different from control: p Q 0.025 using paired Student’s t-test 
b Significantly different from phenylephrine: p < 0.25 using paired Student’s t-test 
Hepatocytes were incubated as described in section 2. Phosphorylase and PDH activities were 
measured 3 min after the addition of phenylephrine. Absolute basal values for oxygen 
consumption were: control, 1.66 f 0.11; yohimbine, 1.64 f 0.17; prazozin, 2.25 f 0.35 rmol 
Oz.min-‘.g-‘; values are means f SEM of 3-4 hepatocyte preparations 
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of phenylephrine on ATP, ADP, pyruvate, Coenzyme A and mitochondrial 
NADH/NAD ratio 
ATP ADP Pyruvate B/A Coenzyme A 
(clmolig) Cumol/g) (nmol/g) (nmol/g) 
Control 3.14 f 0.15 0.88 f 0.09 174 f 29 1.55 f 0.11 103 f 12 
Phenylephrine 
5 x lO-‘j M 3.01 f 0.05 1.00 f 0.11 189 f 38 1.59 f 0.13 103 f 7 
B/A, &hydroxybutyrate/acetoacetate ratio 
Hepatocytes were incubated as described in section 2; 3 min after addition of NaCl or phenylephrine, cells 
were rapidly centrifuged and the pellet frozen in liquid Nz; values are means f SEM of 3 hepatocyte 
preparations 
zyme A, nor mitochondrial NADH/NAD ratio as 
measured by the ,&hydroxybutyrate/acetoacetate 
ratio, were altered 3 min after phenylephrine 
addition. 
3.4. Interaction of phenylephrine with the action 
of insulin and glucagon on PDH activity 
Insulin is able to antagonize the action of 
phenylephrine on phosphorylase activity [21,22]. 
Insulin is also able to increase PDH, but to a lesser 
extent than phenylephrine [23] (table 3). When in- 
sulin is added together with phenylephrine, no 
significant change in PDHa is observed compared 
to phenylephrine alone, whereas in the same ex- 
periments insulin has significantly reduced the ac- 
.-. PHOSPHORYLASE A 
o-o "I:iITIAL" PYRUVATE DEHYDROGENASE 
Fig.2. Sensitivity of phosphorylase and of ‘initial’ 
pyruvate dehydrogenase to phenylephrine in isoIated 
hepatocytes from fed rats. The data are expressed as 
percentages of maximal response of each of the enzymes 
to phenylephrine. Results are from 2 different 
hepatocyte preparations which gave similar results. 
tivity of phosphorylase activated by phenylephrine 
(phenylephrine alone, 22.1 f 1.05; phenylephrine 
+ insulin, 19.9 f 1.04 units/g, p < 0.005 using 
paired Student’s t-test). Glucagon promotes a very 
marked increase in PDH, (table 3). When 
phenylephrine and glucagon are added together at 
concentrations giving maximal response, their ac- 
tion on PDHa is additive. It is also long-lasting 
since 20 min after the addition of the two hor- 
Table 3 
Interaction of phenylephrine with the action of insulin 
and glucagon on ‘initial’ pyruvate dehydrogenase 
activity in hepatocytes from fed rats 
Addition PDH. 
3 min 20 min 
Control 0.40 f 0.04 0.41 i 0.06 
Phenylephrine 
5 x 1O-6 M 0.64 f 0.10* 0.57 f 0.06’ 
Glucagon 10m9 M 0.93 f O.lla 0.65 f 0.06a 
Phenylephrine + 
glucagon 1.23 + 0.088*b 0.97 f 0.12*sb 
Insulin 1 munit/ml 0.56 f 0.10 0.61 f 0.07’ 
Phenylephrine + 
insulin 0.64 f 0.08* 0.65 f 0.07 
a Significantly different from control: p 6 0.025 using 
paired Student’s t-test 
b Significantly different from glucagon alone: p < 0.025 
using paired Student’s t-test 
Hepatocytes were incubated as described in section 2; 
values are means I~I SEM of 4-6 hepatocyte preparations 
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mones, PDHa is still higher than with either hor- 
mone alone. 
4. DISCUSSION 
Phenylephrine rapidly increases ‘initial’ 
pyruvate dehydrogenase activity. This action is not 
observed when hepatocytes are Ca2+-depleted and 
it is blocked by the al-blocker prazozin whereas 
the az-adrenergic blocker yohimbine is without ef- 
fect. The Ca2+ ionophore A23187 is also able to 
promote an increase in PDHa. This agent may 
however act either via an increase in cytosolic 
Ca2+ followed by an increase in mitochondrial 
Ca2+’ or by an increase in fructose 2,dbisphos- 
phate [20] and glycolysis. This would lead to an in- 
crease in pyruvate which could inhibit pyruvate 
dehydrogenase kinase. 
The action of phenylephrine cannot be explained 
by changes in whole cell concentration of ATP, 
ADP, pyruvate, coenzyme A or in the mitochon- 
drial redox state as measured by ,&hydroxy- 
butyrate-acetoacetate ratio since none of them is 
modified at a time when phenylephrine increases 
PDH,. 
Insulin has no effect on phenylephrine- 
stimulated PDH, whereas in the same experiments 
it does slightly, but significantly, decrease 
phosphorylase CI. If the two hormones were acting 
on PDH via the same mechanism one would expect 
an additivity or a potentialisation of their action. 
Since the mechanism of action of insulin on 
phenylephrine-stimulated phosphorylase is not 
known (e.g., decrease in the amount of Ca2+ 
mobilized, modification in the sensitivity of 
phosphorylase kinase to Ca2+) no hypothesis can 
be made on the lack of interrelation of the two hor- 
mones on PDH,. The most unexpected data are 
obtained with giucagon alone or with 
phenylephrine; glucagon by itself increases 
markedly the activity of PDH. Such an action was 
not found in vivo [2] 30 min after injection of the 
hormone. When phenylephrine is added with 
glucagon both at a concentration giving maximal 
effect, a further increase in PDHa is measured 
(table 3) and this increase lasts at least 20 min. This 
suggests that the two agents do not act on the en- 
zyme by the same mechanism. It does not exclude 
that the same activator is involved and that the ac- 
tion of glucagon and of phenylephrine on this ac- 
tivator are additive. Recent data [24] have shown 
that glucagon, in the presence of vasopressin, is 
able to increase calcium content in rat liver 
mitochondria. Since the additivity of glucagon and 
phenylephrine on PDHa is also observed with 
vasopressin (not shown), such a mechanism could 
explain the marked and sustained increase in PDH 
activity. The problem, however, remains open if 
we consider the action of phenylephrine alone. In 
many studies [lo-121, a decreased total mitochon- 
drial Ca2’ has been measured in organelles isolated 
from phenylephrine or vasopressin-treated liver or 
hepatocytes. Phenylephrine has also been shown to 
rapidly decrease free Ca2+ in rat liver mitochondria 
[25]. On the other hand, calcium-dependent in- 
creases in several mitochondrial functions have 
been described after addition of cY-adrenergic 
agents, vasopressin or angiotensin. The 3 agents 
increased transiently NADH fluorescence before 
increasing oxygen consumption [26]. Glucagon 
had the same action. Addition of EGTA suppress- 
ed the action of all the hormones on NADH 
fluorescence [26]. Vasopressin also caused a 
decrease in concentration of 2-oxoglutarate in 
hepatocytes from fed rats [27]. This decrease was 
not observed in the absence of Ca2+ and is consis- 
tent with a Ca2+-dependent activation of 
2-oxoglutarate dehydrogenase [27]. 
In conclusion, we have shown that 
phenylephrine increases PDH, in hepatocytes from 
fed rats. This action is Ca2+-dependent and could 
reflect an increase in mitochondrial Ca’+. 
The present data emphasize the discrepancy bet- 
ween the decreased mitochondrial Ca2+ content 
measured after a-adrenergic agents or vasopressin, 
and the indirect evidence of the Ca2+-dependent 
changes in mitochondrial function (among which 
an increase in PDHJ. 
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